Meet our two new faculty – who, with Phillip Pierorazio, M.D., newly named Director of the Kidney Cancer Program – form a multidisciplinary and translational kidney cancer group.
Nirmish Singla, M.D., M.S.C.S. has joined The Brady as an assistant professor in Urology and Oncology. Singla earned his undergraduate degree in Biomedical Engineering from the University of Michigan, and his M.D. from the University of Michigan Medical School. He completed his residency in Urology at the University of Texas Southwestern Medical Center (UTSW), and spent an additional year there as a postdoctoral research fellow through the NIH/NCI Physician Scientist Training Program. Singla earned a Master of Science in Clinical Science (M.S.C.S.) degree and pioneered a Physician Administrative Fellowship Program at UTSW, and then completed an advanced SUO-accredited clinical fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center. Singla, who is Director of Translational Research in GU Oncology at Johns Hopkins, also treats patients with testicular cancer and urothelial malignancies.
Yasser Ged, M.B.B.S., finished medical oncology higher specialist training with Royal College of Physicians in Ireland, and then completed an Advanced Medical Oncology Fellowship at Memorial Sloan Kettering Cancer Center. Ged’s clinical and research focuses on the management of advanced renal cell carcinoma; specifically, he is studying rare kidney cancers, novel therapeutic agents, and developing immunotherapy biomarkers of clinical benefit.”